Promoter Methylation of the Retinoic Acid Receptor Beta2 (RARβ2) Is Associated with Increased Risk of Breast Cancer: A PRISMA Compliant Meta-Analysis

BACKGROUND: Epigenetic studies demonstrate that an association may exist between methylation of the retinoic acid receptor beta2 (RARβ2) gene promoter and breast cancer onset risk, tumor stage, and histological grade, however the results of these studies are not consistent. Hence, we performed this...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Cheng, Jian, Zhi-Yuan, Shen, Xian-Feng, Wei, Xue-Mei, Yu, Guo-Zheng, Zeng, Xian-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599915/
https://www.ncbi.nlm.nih.gov/pubmed/26451736
http://dx.doi.org/10.1371/journal.pone.0140329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599915/
https://www.ncbi.nlm.nih.gov/pubmed/26451736
http://dx.doi.org/10.1371/journal.pone.0140329

Ejemplares similares